Melquinast
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161545This classification denotes an anti-asthmatic agent with the molecular formula C15H16N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0RO0SEU9AY, chemically known as ethyl 6-ethyl-5,6-dihydro-9-methyl-5-oxo-s-triazolo(1,5-c)quinazoline-2-carboxylate. but generally known as melquinast, which bears US NIH Compound Identifier 3045413. European Medicines Agency schedules Melquinast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08729MIG. The term MELQUINAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). MELQUINAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule melquinast under HS 29335995 and SITC 51576. As of Q4 2014, MELQUINAST remains the US FDA Preferred Term for this commodity. Melquinast bears US NLM identifiers UMLS ID C1881774 and NCI Concept Code C66082. SMILES: O=C1N(C2C(C3N1NC(N3)C(=O)OCC)CC(CC2)C)CC.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.